Introduction
Malignant mesothelioma (MM) is a severe primary neoplastic disease. Its frequency has dramatically increased in recent decades due to occupational exposure to asbestos fibers and the long latency period between first exposure and diagnosis, ranging from 20 to more than 40 years 1, 2 . The growing frequency of mesothelioma was also aggravated by the delayed recognition of asbestos diseases and implementation of asbestos regulations. Despite recent epidemiological data suggesting that the peak of MM incidence may occur sooner than expected, this malignancy remains a major concern in view of the poor results of treatment and reports of mesotheliomas with no known exposure to asbestos in 20% to 40% of cases [3] [4] [5] [6] .
This raises the question of the role of very low levels of asbestos, as described in the context of environmental exposure, or other as yet unidentified risk factors [7] [8] [9] [10] [11] . New manufactured fiber-shaped products may also be of concern, as recent studies have demonstrated that carbon nanotubes (CNT) can reach subpleural tissue in mice 12, 13 and induce inflammation after injection in the peritoneal cavity of mice 14 . Mesotheliomas also occur in genetically-modified cancer-sensitive mice and in conventional Fisher 344 rats exposed to CNT by intraperitoneal and intrascrotal administration, respectively 15, 16 .
To improve the outcome of MM, a better knowledge of the somatic alterations in neoplastic cells is necessary in order to improve diagnosis, treatment and prognosis. Several techniques are available to identify MM genomic alterations, such as cytogenetics, comparative genomic hybridization (CGH) and single nucleotide polymorphism (SNP) array, or gene mutations by DNA sequencing. Data from the literature show that most human MM cases exhibit complex patterns of cytogenetic changes with chromosomal losses being more frequent than gains and numerous partial or total chromosome losses have been shown to be recurrent [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] . Somatic molecular abnormalities affecting tumor suppressor genes (TSGs) have also been described in human MM. They mainly consist of codeletion of p16/CDKN2A, Page 5 p14/ARF and p15/CDKN2B genes, and mutations of the NF2 gene in approximately one half of cases. In contrast, the TP53 TSG is less frequently inactivated [27] [28] [29] [30] .
Murine models of mesothelioma have been recently developed in wild-type (WT) and hemizygous Nf2 +/-mice after asbestos exposure by intraperitoneal inoculation, offering an unique opportunity to more clearly characterize the genomic changes caused by asbestos on mesothelial cells [31] [32] [33] . These animals developed mesotheliomas 9 to 24 months after exposure, with frequent occurrence of ascitic fluid. Nƒ2 hemizygosity resulted in a higher rate of mesothelioma when compared to WT mice, with no significant difference in terms of time to tumor occurrence 31 . Mesothelioma cells isolated from tumor ascites obtained from these mice displayed similar gene mutations as human MM, characterized by frequent LOH at the Nƒ2 locus in Nƒ2 +/-mice and, in all genetic backgrounds, frequent inactivation of p16/Cdkn2a, p19/Arf, p15/Cdkn2b TSGs and infrequent inactivation of Trp53 32, 34, 35 . Only limited data on global analysis of genomic alterations have been reported to date in rodents. Only recurrent alterations in chromosome 4 were described in murine mesothelioma cells 36 . A CGH study was also performed in rats after intraperitoneal administration of iron saccharate 37 .
The present study was designed to investigate genomic alterations in MM by comparing the genomic profile of human MM cases to that of fiber-induced murine MM assessed by array-comparative genomic hybridization (aCGH). Genomic profiles showed numerous alterations in both species with fifteen similar regions of chromosome imbalance.
In human MM cells, a link was found between genomic instability and the ability of MM xenografts to develop subcutaneous tumors in immunocompromized mice. Our data also suggest that loss of human 14q11.2-q21 region is related to asbestos exposure.
These results suggest that genes in altered regions may be damaged or deregulated by asbestos exposure, and may subsequently sustain carcinogenesis. Research is currently Page 6 underway to identify the genes, gene families and pathways involved in mesothelial carcinogenesis.
Materials and Methods

Mesothelioma cells
Murine mesothelioma cells were obtained from previous experiments in which mineral fibers, asbestos and carcinogenic refractory ceramic fibers (RCF) were inoculated into the peritoneal cavity of WT and NF2+/-mice. This strategy allowed the generation of mesotheliomas mimicking the morphology and histopathology of the corresponding human cancer 31, 35 . Sixteen cell cultures were established from tumor ascites obtained from 12 Nf2
+/-mice and 4 WT mice, as reported elsewhere 31 . The mesothelial origin was assessed by immunocytochemistry using cytokeratin and vimentin antibodies according to a previously described method 31 . Histological subtypes were epithelioid (15.4%), sarcomatoid (30.8%) and mixed (53.8%) MMs. Histopathological features of murine mesotheliomas were independent of the fiber type, asbestos or RCF. The genetic background did not influence tumor morphology or genetic alterations, apart from more frequent LOH at the NF2 locus in Nƒ2 +/-mice 34 .
Thirty five human cell cultures were obtained from confirmed malignant mesothelioma cases: 29 males (82.8%) and 6 females (17.2%) with a mean age of 63 ± 11 years and 69 ± 5 years, respectively (mean ± standard deviation). The study was approved by the local Ethics Committee and human cells were obtained with the informed consent of the patients. Detailed information about the tumors was obtained from pathology reports. Most cases were epithelioid subtypes (80%). Sarcomatoid and mixed subtypes of MM were observed in 6.7% and 13.3% of cases, respectively. Patients' asbestos exposure was estimated by interviewer-administered questionnaire. This questionnaire comprised complete job history, including past occupational, domestic, and environmental exposures to asbestos. It was completed by face-to-face interview 38 . In this series, asbestos exposure was ascertained in 24 MM cases, 2 cases were possibly exposed and no exposure was found in 8 cases. In one case, no data was available on asbestos history.
DNA extraction and qualification
Cells were grown in RPMI 1640 medium with Glutamax and 25 mM HEPES, supplemented with 8% fetal calf serum, 50 IU/ml penicillin and 50 mg/ml streptomycin (Invitrogen, Cergy Pontoise, France). All genetic analyses were carried out with cultures of less than 10 passages. Genomic DNA was extracted as previously described 34 , quantified by absorption measurement, and qualified by deposition of 100 ng on a 0.8% agarose gel. DNA ladder was λHindIII (Invitrogen).
Human and murine aCGH. 43 .
Amplifications and bi-allelic deletions were defined by a normalized fluorescence ratio greater than 3 and less than 0.5, respectively. Recurrent regions of chromosomal alteration were defined as regions that encompassed at least two adjacent probes that were both gained or lost.
Gene alterations analysis.
Gene mutations and deletions were analyzed from genomic DNA extracted from all murine and human MM cases. PCR amplifications and sequencing were carried out on a 
Results
Genomic characterization of murine mesotheliomas.
The molecular profile of murine mesotheliomas was investigated in a series of 16 murine mesotheliomas. An overview of chromosome alteration patterns is presented in Figure   1 . This analysis revealed numerous genomic alterations, with an average of 10.7 altered autosomes per tumor (range: 4-18). Interestingly, these alterations were mostly gains or losses of entire chromosomes. Recurrent regions of chromosomal alterations were then defined as regions with at least two adjacent probes gained or lost at a frequency higher than 30% (Table   1 ). Frequent recurrent gained regions (more than 50% of cases) included: chr15 (75-81%),
19qC3-qD2 (75%), 19qA-qC1 (63-75%), 6qA1-qB1 (50%-56%), 8qC2-qC5 (50%) and frequent losses included regions in 4qC4-qD1 (50-81%), 14qD3-qE2.1 (50-69%), 4qD3-qE2.1 (50-63%), chr7 (56-63%) and 14qb (50%) (supplementary Figure 1s .A-C, see Figure 1s at http://ajp.amjpathol.org). Minimal regions of chromosomal loss were then delineated on the basis of the alteration frequency and the presence of an interstitial deletion in at least two MMs in order to identify potential tumor suppressor genes and the miRNAs lost in murine mesothelioma cells (Table 2 Four regions of homozygous deletions were observed including Sav1, the putative TSG involved in the Hippo signaling pathway as candidate target gene (Table 2) .
Genomic characterization of human mesotheliomas
The genomic characterization of a series of 35 human MMs also demonstrated a high rate of rearrangements ( Figure 2 ). Two tumors displayed up to 21 altered autosomes (mean of 13.8 altered autosomes per tumor; range: 1-21). However, most alterations did not involve entire chromosome, and monoallelic gains were less frequent than in murine MMs. Nine recurrent regions of loss with a frequency higher than 50% were observed: 9p22-p13 (51%-
4q21-q24 (51%-54%), 12p13 (54%), 1p36.3 (51%), 6q24-q25 (51%) and only one region of gain was observed: 5p15. higher than 30% are shown in Table 3 . Ten high-level gained regions and twelve regions containing homozygous deletions were detected ( 
Humanized murine aCGH
Syntenic analysis of the murine genomic profiles revealed similarities between their humanized profiles and the genomic profiles obtained from the human series of MM. In particular, twelve regions recurrently altered (frequency higher than 30%) in both the human disease and in the mouse model were identified (Table 5) 
Human candidate genes associated with minimal regions of chromosomal imbalance
To determine genes or miRNAs potentially involved in human mesothelial carcinogenesis, minimal altered regions were defined on the basis of several criteria. First, CGH array data were compared between murine and human MMs and four minimal regions of loss were delineated in both species: 1p36.3, 1p36.1, 9p21 and 13q21 (Table 6 and supplementary Figure 2s .A,B,I,M, see Figure 2s at http://ajp.amjpathol.org). The 9p21 region, which encompassed the CDKN2A and CDKN2B genes, showed the highest alteration frequency in both species. The presence of homozygous deletions in this region was also detected in 63% and 40% of human and murine MMs, respectively (Table 5) . Three other regions also contained putative TSG, such as CHD5 (1p36.3), NBL1 (1p36.1), PCDH9 and DACH1 (13q21). Interestingly, the 13q21 region, in which one of the human MMs showed a Page 13 homozygous deletion (Table 4) , contained only three coding genes (Table 6 ). Second, thirteen new minimal regions of chromosomal loss in human MM were defined on the basis of the alteration frequency and the presence of an interstitial deletion in at least three MMs (Table 6 and supplementary Figure 2s .A-Q, see Figure 2s at http://ajp.amjpathol.org). Seven of these regions (3p21, 4q22-23, 6q24-q25, 10q23-q24, 12p13, 13q13 and 15q14-q21) contained genes that have been previously described as being involved in cancer progression, as shown in Table 6 . The other six regions (1p22-p21, 4p16-p15.3, 4q13, 6q22, 9p22, 9p11.1 and 15q14-q21) did not contain any potential TSG, but encompassed several miRNAs loci. Third, despite the entire loss of 22q in 57% of human MMs, the smaller q12-q13 region, characterized by the highest alteration frequency (80%), was delineated. This region contains two potential genes previously described to be involved in tumor progression (EP300, BIK) and four miRNAs ( Table 6 (Table 4) .
Gene mutations in human and murine MM
The rate of mutations in human TP53, CDKN2A/CDKN2B, and NF2 genes, and in the orthologous murine genes are reported in Table 7 , confirming previously published data, but based on a larger series 34, 35, 44 and losses in Hs 3p23-p14, Hs 6q14-q27 and Hs 10p15-p12 were observed in more than 50%
and 0% of epithelioid and sarcomatoid subtypes, respectively. In mice, loss of Mm 2qE1-qE3
showed the same distribution. At the opposite, Mm 1qH2.1-qH5 and Mm 16qA1-qB3 alterations showed a frequency higher than 50% in sarcomatoid subtypes and 0% in epithelioid subtypes. However, there were no similarities between human and mouse MM in terms of type and location of recurrent alterations according to histological subtype.
Association between genomic alterations and xenograft growth of human MM cells
Tumorigenicity of 32 human MM cells was determined in immunocompromised mice.
In vivo tumor growth was observed with 23 MMs. For each case, the tumorigenic potency was compared to that of genomic alterations. Several recurrent genomic alterations were more frequent in tumorigenic (T) than in non-tumorigenic (NT) human MM, corresponding to Page 15 losses in 3p23-p14 (T: 74%; NT: 33%), 1p31-p12 (T: 52%; NT: 22%), 10p15-p12 (T: 43%;
NT: 22%) and 17p13-p11.2 (T: 43%; NT: 22%), and gain in 5p15.3-p11 (61%; NT: 33%).
Statistical comparison between the occurrence of minimal regions of chromosomal alterations (Table 6 ) and this biological feature revealed that losses of 1p22-p21 (p<0.05), 3p21 (p<0.05), and 9p22 (p<0.02) regions were more frequent in tumorigenic than in non-tumorigenic MM.
Interestingly, the 3p21 region contained several genes previously described as being involved in tumor progression (SETD2, MST1R, PLXNB1, RASSF1, RBM5, SEMA3B, SEMA3F,
HYAL1, HYAL2).
The number of breakpoints across the 22 autosomes was quantified in order to estimate genomic instability in human MM. Breakpoints were defined as the junction between a non-altered chromosomal region and a lost region. The breakpoint index, which corresponds to the sum of all breakpoints observed, ranged from 2 to 35 with a median of 22.5 ( Figure 3 ).
Interestingly, a statistically significant correlation was demonstrated between a high breakpoint index and the ability of MMs to develop a tumor in nude mice (p=0.031).
Comparative genomic alterations related to fiber exposure
Comparison of recurrent regions of chromosomal alterations between asbestosexposed (24 cases) and non-exposed (8 cases) patients showed a difference in the 14q11.2-q21 region (Figure 4) . The maximum frequency of chromosomal alterations was 46% and 0% in asbestos-exposed and non-exposed cases, respectively (p<0.03). In our murine model of fiber-induced MM, the syntenic regions 12qB3-qC1 and 14qC1-qC2 were also altered at a frequency of 44% (Table 5) . 37 . Epithelioid MMs showed minimal alterations, while a few chromosomal amplifications and deletions were found in sarcomatoid MM including homozygous deletion of the Cdkn2a/Cdkn2b locus. Further studies would be necessary to determine whether these differences are related to the type of MM-inducing agent and/or to species specificities. However, Cdkn2a/Cdkn2b locus deletion seems to be an independent and specific feature of MM.
Human MMs have been previously studied by various cytogenetic methods, classical CGH, CGH array, SNP array and representational oligonucleotide microarray analysis (ROMA). Human MM is characterized by frequent losses of chromosomes 1p, 3p, 4, 6, 9p, 13q, 14q and 22q, and gains mostly involving chromosomes 5p, 7p, 8q and 17q [21] [22] [23] [24] [25] [26] 45, 46 . In agreement with data in the literature, aCGH in our series detected chromosomal losses in similar regions, confirming the recurrence of these alterations in human MM. Other regions of Page 17 loss identified in 8p, 10p, 14q, 15q, 17p, 18q, 19p and 19q have also been reported in some studies 47, 48 . In the 12p region, a translocation breakpoint with X chromosome was described in one human MM 49 . In the present study recurrent regions of gain were only identified in 5p, Table 1s , see Table 1s at http://ajp.amjpathol.org). Nevertheless, a higher frequency of alterations was observed in MM cultured cells probably due to contamination of tumor specimens by normal tissue.
Similarities and differences were clearly demonstrated after "humanizing" murine MM genomic profiles. The most striking similarity between human disease and its mouse model is the deletion of CDKN2A/CDKN2B locus, with a frequency as high as 91% and 81% in humans and mice, respectively, and this deletion is frequently bi-allelic in both species (Table 5) . These results are in agreement with published data reporting that CDKN2A/CDKN2B deletions are a feature of MM 28, 29, 50, 51 . The present results suggest codeletion of CDKN2A and MTAP (methylthioadenosine phosphorylase), a gene under study as a potential therapeutic target 51, 52 . Interestingly, the orthologous Mtap gene is located in the syntenic region (Mm chr4C4), and could be accordingly co-deleted with Cdkn2a in the murine genome.
Loss of Hs 1p36.3-p35 (Mm 4qD2.3-4qE2) is another notable similarity. Deletions in the short arm of chromosome 1 are a well known feature of human MM 53, 54 , and were associated with high asbestos exposure level in one study 55 . In our series, losses of 1p36.3 Page 18 were found in 51% and 63% of cases in human and murine MM, respectively (Table 5) . One gene, CHD5, may be of interest in this region. CHD5 is involved in chromatin remodelling, and has been defined as a tumor suppressor gene 56 . Monoallelic loss of this gene was observed in several human MMs in the present series. Other studies reported that CDH5 inactivation was associated with silencing of the second allele by an epigenetic mechanism, as in neuroblastoma and several carcinomas 57, 58 .
The minimal region of common deletion between Hs 13q14-q33 and Mm 14qD1-qE2.3 was found at a frequency of 58% and 69%, respectively. The minimal region of deletion, 13q21, contains only three genes, PCDH9, KLHL1 and DACH1. Interestingly, a biallelic deletion was found in this region in one human MM. PCDH9 is a member of the protocadherin family, involved in oncogenesis 59 . PCDH9 was found to be mutated in one pancreatic primary tumor 60 and DACH1 is a nuclear factor playing a role in breast, prostate and ovary cancers 61 .
The 5p15.3-p13 gains reported in human MM were found in different syntenic regions of the mouse genome (Table 5 ). Many genes of interest are located in these regions, including several cadherins, PRMD9, SKP2 and RAD1. TERT is located in 5p15.3, a recurrent region of gain in human MM, but not in the syntenic mouse region. 5p15.3 was also amplified in one human MM. Telomerase activity has been reported in a high proportion of human pleural MM, and telomere maintenance was recently reported to be due to both telomerase activity and alternative lengthening of telomeres in peritoneal MM 62, 63 . Tert appears to be constitutively active in most murine cells 64 , and the Mm 13qC1 region in which it is located is not deleted in murine MM, in accordance with a potential role of this enzyme in both species.
In contrast, several regions of genomic alterations differed between human and murine MMs. In the present series, a high rate of deletions was detected in Hs 22q mainly consisting of loss of the entire chromosome, and NF2 inactivation is a specific alteration in MM 18, 27, 53, 55 . Page 19 Monoallelic deletions at NF2 were found in 71% of cases, and a biallelic deletion was observed in one MM. Lower percentages were observed in murine MM genomic profiles.
However, genetic analyses confirmed loss of Nƒ2 in murine MM, in agreement with a role of this gene in mesothelial carcinogenesis (Table 7) . The Nƒ2 gene has been shown to enhance the incidence of MM in mice without shortening the latency, in comparison with WT mice, supporting a role as a susceptibility factor, a hypothesis previously formulated in human MM 65 . Furthermore, MM occurred at a higher incidence when mice knockout for Nf2 were co-inactivated for either Ink4a/Arf or Trp53 66 . These observations indicate that inactivation of other genes potentiates Nf2 gene loss and substantially contributes to development of MM.
Other genes located in Hs 22q could also play a role in mesothelial carcinogenesis, such as EP300 and BIK located in the region lost at the highest frequency. Further studies should be developed to identify other genes relevant to mesothelial oncogenesis.
Deletions of 3p regions are among the most frequent alterations in human cancers, including human MM. Frequent loss of the Hs 3p21 region , in which several candidate genes are located, was observed, but not in mice. A cluster of tumor suppressor genes has been reported in the 3p21.3 region, including Ras-associated factor 1 (RASSF1), which appears to be inactivated by methylation in MM [67] [68] [69] . Alterations in this 3p21 region were significantly more frequent in human MM exhibiting tumorigenicity in nude mice than in non-tumorigenic MM, suggesting an important role of the associated genes in tumor formation. However, as for chromosome 22, the syntenic region of human 3p21 was not altered accordingly in mice.
These differences could be explained by technical issues, including differences in resolution of human and murine arrays used for genomic profiling, as well as species specificities.
Other regions of chromosome imbalance found exclusively in human MM contain well known TSG such as BRCA2 (13q13, 60% frequency of loss) or PTEN (10q23-24, 37%
frequency of loss). Downregulation of PTEN has been previously described in human MM 70 . Page 20 In contrast, some recurrent regions of chromosomal alterations did not contain any potential TSG or oncogene, but encompassed loci of several miRNAs. Differential expression of miRNAs has been previously observed between mesothelioma and mesothelial cells 71, 72 .
Copy number alteration is one of the mechanisms affecting miRNAs gene expression.
MiRNAs are thought to act as TSGs and oncogenes due to their ability to modulate the transcriptional regulation of their target genes. Indeed, MIR31, located in the 9p21 recurrently lost region (Table 6 ), was recently demonstrated to inhibit cell proliferation and invasion of mesothelioma cells 73 . Further investigations of other miRNAs, such as MIR760, MIR137 and MIR553, would be of interest. These miRNAs are located in 1p22-21, a region devoid of coding genes, but altered at a higher frequency in tumorigenic MM than in non-tumorigenic human MM. The present study identified several miRNAs which could be deregulated in both human and murine MMs.
Comparison of recurrent regions of chromosomal alterations according to MM histology showed different frequencies between epithelioid and sarcomatoid subtypes. While the differences are not significant, at least partly due to the low power of the statistical analysis, they are likely species-dependent. This suggests that recurrent regions of chromosomal alterations are characteristic of a given subtype only in a given species.
Differences in the proportion of histological subtypes between human and mouse complicated comparison between these two species. Several authors emphasized that epithelioid MM is more frequent in human than in mouse following asbestos exposure [31] [32] . More recently, Jongsma et al. 66 found the same result in spontaneous MM identified in mice carrying conditional TSG knockout alleles for Nf2, Trp53 and Ink4a/Arf. In this study, eight different series of mice carrying co-inactivation of 2 or 3 TSGs were studied. The proportion of different subtypes was dependent on the genetic background with epithelioid MM being under represented in all but one series. These authors suggested that the predominant epithelioid Page 21 MM subtype seen in human opposed to mouse may occur as a result of species specific differences or relate to the route of MM induction. Our results would better suggest a species specific difference.
An interesting finding was the relationship between chromosomal instability, estimated by the number of breakpoints, and the ability of human MM xenografts to develop subcutaneous tumors in nude mice. To the best of our knowledge, this relationship with tumor aggressiveness has not been previously reported in mesothelioma. However, in other types of cancer, an increase in chromosomal aberrations is associated with higher grade and stage of tumors, which is consistent with increased genomic instability observed in tumor development and progression 74, 75 . It would be of interest to determine whether the number of breakpoints could be a useful prognostic factor for MM progression.
The present study identified one recurrent region of chromosome loss, 14q11.2-q21, in asbestos-exposed patients not found in non exposed patients, but also lost in the syntenic region in mice mesotheliomas, suggesting that this region might be a target of action of mineral fibers. Frequent allelic loss has been detected in this region in human MM 21, 76 .
However, to date, it has been related to asbestos exposure in only one study by LOH in the 14q11 region involving LRP10, a member of low-density lipoprotein receptorrelated proteins, in one patient with a history of asbestos exposure.
In conclusion, despite certain differences, our results show common genomic alterations between genomic profiles in murine and human MM and suggest that they can be of importance to account for asbestos-induced mesothelial cell neoplastic transformation. Page 22 Genes at the CDKN2A/ CDKN2B locus may play an important role in this process by committing cells to carcinogenic transformation. It would be of interested to determine whether other genes located in common regions of chromosomal imbalance in these two species could be involved in mesothelioma transformation. Genomic profiling of human and murine MM cells reported here validates the mouse model as a useful model to study the molecular mechanisms of this disease, and to test innovative therapeutic approaches. New generations of genomic profiling tools in combination with expression analysis will be useful to identify target genes involved in this dreadful disease. Corresponding mouse chromosomal regions are shown when alteration frequency of BAC clones are higher than 30%. Alteration frequency of each BAC clones are also specified for each group.
